Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Equillium, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 25 | 1 | 26 | +2 |
| Shares | 8.89M | 38.3K | 8.72M | −131.5K (−1.5%) |
| Value | $6.15M | $26.6K | $7.25M | +$1.12M (+18.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Equillium, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 40,165 | $33.4K | 0.00% |
| GWM Advisors LLC | 17,700 | $14.7K | 0.00% |
| Two Sigma Securities, LLC | 17,494 | $14.6K | 0.00% |
| XTX Topco Ltd | 16,955 | $14.1K | 0.00% |
| Virtu Financial LLC | 14,152 | $12.0K | 0.00% |
| Lazard Asset Management LLC | 1,594 | $1.00K | 0.00% |
| Barclays PLC | 104 | $87 | 0.00% |
Sold out (5)
Institutions that held Equillium, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 43,504 | $30.2K |
| Integrated Wealth Concepts LLC | 40,000 | $27.7K |
| Tritonpoint Wealth, LLC | 13,500 | $9.36K |
| Stifel Financial Corp | 10,119 | $7.01K |
| Royal Bank of Canada | 29 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Equillium, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 38,317 | $26.6K |